Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001628280-21-000060

Chief Executive Officer gave up 113 shares (to pay taxes)

  • Chief Executive Officer acquired 260 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Erlander Mark Chief Executive Officer 2021-01-02 Option exercise +260 13,629 D
Erlander Mark Chief Executive Officer 2021-01-02 Shares withheld for taxes −113 13,516 D
Derivatives
Erlander Mark Chief Executive Officer 2021-01-02 Option exercise · Restricted Stock Units −260 0 D
Loading xslF345X03/wf-form4_160988059527289.xml…